We are pleased to announce the closing of a previously announced short form prospectus offering, on a bought deal basis, including the full exercise of the over-allotment option. As such, a total of 11,339,000 common shares of the Company were sold at a price of $3.55 per Share, for aggregate gross proceeds of $40,253,450.
Full release can be viewed here.